跳到主要內容區塊

8.Biological and clinical significance of the AGE-RAGE axis in the aggressiveness and prognosis of prostate cancer
| 發布日期:2023-12-21 | 更新日期: 發布單位:

Biological and clinical significance of the AGE-RAGE axis in the aggressiveness and prognosis of prostate cancer

Shih-Hong Khooa†, Pei-Ru Wu b,c†, Kun-Tu Yehc,d,e, Shih-Lan Hsuf and Chi-Hao Wug*

aSchool of Nutrition and Health Sciences, College of Nutrition, Taipei Medical University, Taipei 110301, Taiwan

bDepartment of Pathology, Cheng-Ching General Hospital, Taichung 40764, Taiwan

cDepartment of Surgical Pathology, Changhua Christian Hospital, Changhua 50006, Taiwan

dSchool of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan

eDepartment of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung 40227, Taiwan

fDepartment of Medical Research, Taichung Veterans General Hospital, Taichung 40705, Taiwan

gGraduate Program of Nutrition Science, School of Life Science, National Taiwan Normal University, Taipei 11677, Taiwan

Dietary factors and chronic hyperglycemia are linked to the formation of advanced glycation end products (AGEs) and prostate cancer (PCa) risk. The activation of the receptor for AGEs (RAGE) acts as a bridge between various RAGE ligands and certain malignancies. This study showed that the interaction of AGEs and RAGE promoted PCa cell proliferation, invasion, and autophagy-mediated survival in response to chemotherapeutic agents. RAGE-overexpressed PCa cells underwent epithelial-mesenchymal transition and showed increased cancer stem cell-like properties. In mouse xenograft models, RAGE-overexpressed cells showed more substantial tumorigenic capacity than parental cells, whereas RAGE knockdown decreased tumorigenicity. The clinical data validated a positive correlation between high AGE and RAGE expressions with poor clinical outcomes. Our findings suggest that the AGE-RAGE axis facilitates PCa progression and aggressiveness. Prostatic AGEs and RAGE expression levels are associated with PCa prognosis. Adherence to a reduced-AGE diet and targeting RAGE are potential approaches to complement and synergize with the current PCa therapies.

Keywords: Advanced glycation end products, Aggressiveness, Glycative stress, Prostate cancer, RAGE

https://doi.org/10.38212/2224-6614.3475

(https://www.jfda-online.com/journal/vol31/iss4/8/)
檔案下載